These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 1988120

  • 21. Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.
    Houlihan WJ, Lee ML, Munder PG, Winslow CM, Cheon SH, D'Aries FJ, DeLillo AK, Jaeggi CS, Mason RB, Parrino VA.
    J Lipid Mediat; 1990; 2(5):295-307. PubMed ID: 2133273
    [Abstract] [Full Text] [Related]

  • 22. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V, Mascarucci P, De Simoni MG, Jiang X, Bindoni M.
    Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
    [Abstract] [Full Text] [Related]

  • 23. The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a).
    Kawano Y, Furukawa Y, Fukuda J, Matsumoto H, Yuge A, Narahara H.
    Am J Reprod Immunol; 2007 Nov; 58(5):434-9. PubMed ID: 17922696
    [Abstract] [Full Text] [Related]

  • 24. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
    Zhang Q, Pan J, Zheng RL, Wang Q.
    Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
    [Abstract] [Full Text] [Related]

  • 25. Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
    Barzaghi G, Sarau HM, Mong S.
    J Pharmacol Exp Ther; 1989 Feb; 248(2):559-66. PubMed ID: 2537401
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [Abstract] [Full Text] [Related]

  • 27. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z, Wolf MB.
    Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
    [Abstract] [Full Text] [Related]

  • 28. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
    Jan CR, Chao YY.
    Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
    [Abstract] [Full Text] [Related]

  • 29. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M, Nishioka E, Kanoh R, Tachibana M, Fukuishi N.
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [Abstract] [Full Text] [Related]

  • 30. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007 Dec; 26 Suppl 1():3-106. PubMed ID: 17365137
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
    Seewald MJ, Olsen RA, Sehgal I, Melder DC, Modest EJ, Powis G.
    Cancer Res; 1990 Aug 01; 50(15):4458-63. PubMed ID: 2369723
    [Abstract] [Full Text] [Related]

  • 32. [Inhibitory effects of several antitumor drugs on the growth of HL-60 cells in SRC of mice].
    Jing Y, Han R.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Oct 01; 14(5):361-4. PubMed ID: 1299540
    [Abstract] [Full Text] [Related]

  • 33. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F, Fernández-Luna JL, Gajate C, Martín-Martín B, Benito A, Martínez-Dalmau R, Modolell M.
    Cancer Res; 1997 Apr 01; 57(7):1320-8. PubMed ID: 9102220
    [Abstract] [Full Text] [Related]

  • 34. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE.
    J Lipid Mediat; 1993 Aug 01; 8(1):31-51. PubMed ID: 8257776
    [Abstract] [Full Text] [Related]

  • 35. Platelet-activating factor triggers the phosphorylation and activation of MAP-2 kinase and S6 peptide kinase activity in human B cell lines.
    Franklin RA, Mazer B, Sawami H, Mills GB, Terada N, Lucas JJ, Gelfand EW.
    J Immunol; 1993 Aug 15; 151(4):1802-10. PubMed ID: 7688385
    [Abstract] [Full Text] [Related]

  • 36. A differential assay of NK-cell-mediated cytotoxicity in K562 cells revealing three sequential membrane impairment steps using three-color flow-cytometry.
    Kasatori N, Ishikawa F, Ueyama M, Urayama T.
    J Immunol Methods; 2005 Dec 20; 307(1-2):41-53. PubMed ID: 16246359
    [Abstract] [Full Text] [Related]

  • 37. Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A.
    Maggi M, Bonaccorsi L, Finetti G, Carloni V, Muratori M, Laffi G, Forti G, Serio M, Baldi E.
    Cancer Res; 1994 Sep 01; 54(17):4777-84. PubMed ID: 7520361
    [Abstract] [Full Text] [Related]

  • 38. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 39. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD, Morrison WJ, Dhar A.
    Mol Pharmacol; 1989 Apr 15; 35(4):409-13. PubMed ID: 2539556
    [Abstract] [Full Text] [Related]

  • 40. B-cell activation and regulation of immunoglobulin synthesis by platelet activating factor.
    Mazer BD, Sawami H, Franklin R, Gelfand EW.
    Neth J Med; 1991 Oct 15; 39(3-4):244-53. PubMed ID: 1791887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.